Allan Reine
2018 - Pieris Pharmaceuticals
In 2018, Allan Reine earned a total compensation of $871.3K as Chief Financial Officer at Pieris Pharmaceuticals, a 56% decrease compared to previous year.
Compensation breakdown
| Bonus | $131,325 |
|---|---|
| Option Awards | $309,145 |
| Salary | $386,250 |
| Other | $44,542 |
| Total | $871,262 |
Reine received $386.3K in salary, accounting for 44% of the total pay in 2018.
Reine also received $131.3K in bonus, $309.1K in option awards and $44.5K in other compensation.
Rankings
In 2018, Allan Reine's compensation ranked 9,819th out of 14,244 executives tracked by ExecPay. In other words, Reine earned more than 31.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,819 out of 14,244 | 31st |
Division Services | 1,719 out of 2,377 | 28th |
Major group Engineering, Accounting, Research, Management, And Related Services | 125 out of 169 | 26th |
Industry group Research, Development, And Testing Services | 37 out of 51 | 28th |
Industry Commercial Physical and Biological Research | 33 out of 45 | 27th |
Source: SEC filing on June 18, 2019.
Reine's colleagues
We found two more compensation records of executives who worked with Allan Reine at Pieris Pharmaceuticals in 2018.